Tyra Biosciences, Inc.
TYRA
$25.37
$0.351.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.14% | -39.64% | -32.31% | -24.37% | -50.24% |
| Total Depreciation and Amortization | -1.43% | -3.50% | -8.33% | 3.15% | 11.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.78% | 40.78% | 35.91% | 19.94% | 122.96% |
| Change in Net Operating Assets | 409.68% | 59.27% | 710.38% | 765.22% | -124.14% |
| Cash from Operations | -31.23% | -27.94% | -20.59% | -25.04% | -130.84% |
| Capital Expenditure | -112.90% | -528.57% | -850.00% | 25.00% | 93.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.25% | -475.02% | 394.46% | -168.34% | 114.46% |
| Cash from Investing | -14.43% | -475.46% | 394.06% | -168.68% | 114.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 260.55% | 7,329.49% | 563.31% | -12.92% | -6.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 260.55% | 7,233.47% | 563.31% | -12.92% | 56.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -398.43% | -13.56% | 229.43% | -930.05% | 98.56% |